Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.

Bao SunFazhong HeYongchao GaoJiecan ZhouLei SunRong LiuHeng XuXiaoping ChenHonghao ZhouZhaoqian LiuWei Zhang

Published in: Endocrine (2019)

This prospective cohort study showed that glycemic variability was significantly lower for GC than IC and PC. Furthermore, glycemic variability was associated with the risk of MACE and hypoglycemia in total patients and subgroups of different glycemic control.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
end stage renal disease
insulin resistance
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
metabolic syndrome
adipose tissue
risk assessment
climate change
high resolution